# HEAD-Study Optimizing the Treatment of Children With BECTS

> **NCT00471744** · PHASE3 · TERMINATED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 44 (actual)

## Conditions studied

- Epilepsy, Rolandic

## Interventions

- **DRUG:** Treatment with levetiracetam or sulthiame over a six-month period.

## Key facts

- **NCT ID:** NCT00471744
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** low patient number after 2 years recruiting
- **Last updated:** 2009-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471744, "HEAD-Study Optimizing the Treatment of Children With BECTS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00471744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*